Evidence map›Paper›PMID 29851775›Full record

Observational studyMedicine2018

Viral suppression and viral rebound among young adults living with HIV in Canada.

Alexis Palmer, Karyn Gabler, Beth Rachlis, Erin Ding, Jason Chia, Nic Bacani, Ahmed M Bayoumi, Kalysha Closson, Marina Klein, Curtis Cooper and 5 more

Abstract readComparative StudyObservational Study
In one paragraph

Observational study in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alexis PalmerBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC The Ontario HIV Treatment Network Dalla Lana School of Public Health, University of Toronto St. Michael's Hospital, Toronto, ON Department of Medicine, McGill University Health Centre, Montreal, QB The Ottawa Hospital Research Institute, University of Ottawa, Ottawa Toronto General Research Institute, University Health Network, Toronto, ON Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
Karyn Gabler
Beth Rachlis
Erin Ding
Jason Chia
Nic Bacani
Ahmed M Bayoumi
Kalysha Closson
Marina Klein
Curtis Cooper
Ann Burchell
Sharon Walmsley
Angela Kaida
Robert Hogg
Canadian Observational Cohort (CANOC) Collaboration

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Describe the prevalence and covariates of viral suppression and subsequent rebound among younger (≤29 years old) compared with older adults.A retrospective clinical cohort study; eligibility criteria: documented HIV infection; resident of Canada; 18 years and over; first antiretroviral regimen comprised of at least 3 individual agents on or after January 1, 2000.Viral suppression and rebound were defined by at least 2 consecutive viral load measurements <50 or >50 HIV-1 RNA copies/mL, respectively, at least 30 days apart, in a 1-year period. Time to suppression and rebound were measured using the Kaplan-Meier method and Life Table estimates. Accelerated failure time models were used to determine factors independently associated with suppression and rebound.Younger adults experienced lower prevalence of viral suppression and shorter time to viral rebound compared with older adults. For younger adults, viral suppression was associated with being male and later era of combination antiretroviral initiation (cART) initiation. Viral rebound was associated with a history of injection drug use, Indigenous ancestry, baseline CD4 cell count >200, and initiating cART with a protease inhibitor (PI) containing regimen.The influence of age on viral suppression and rebound was modest for this cohort. Our analysis revealed that key covariates of viral suppression and rebound for young adults in Canada are similar to those of known importance to older adults. Women, people who use injection drugs, and people with Indigenous ancestry could be targeted by future health interventions.

Indexed as

AdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveCanadaCD4 Lymphocyte CountDrug Therapy, CombinationFemaleHealth Services, IndigenousHIV InfectionsHumansMaleMiddle AgedPopulation GroupsPrevalenceRetrospective StudiesSubstance Abuse, IntravenousAnti-HIV Agents

Identifiers

PMID29851775
PMCPMC6392935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.